Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 54733
HGNC: 23615
Ensembl: ENSG00000110660
Variants:
dbSNP: 54733
ClinVar: 54733
TCGA: ENSG00000110660
COSMIC: SLC35F2
RNA/Proteins
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37740007 | 2023 | SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. | 4 |
| 37801987 | 2023 | βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells. | 0 |
| 37740007 | 2023 | SLC35F2-SYVN1-TRIM59 axis critically regulates ferroptosis of pancreatic cancer cells by inhibiting endogenous p53. | 4 |
| 37801987 | 2023 | βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells. | 0 |
| 33418944 | 2021 | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells. | 7 |
| 34815782 | 2021 | USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2. | 10 |
| 33418944 | 2021 | SLC35F2, a Transporter Sporadically Mutated in the Untranslated Region, Promotes Growth, Migration, and Invasion of Bladder Cancer Cells. | 7 |
| 34815782 | 2021 | USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2. | 10 |
| 29274137 | 2018 | Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis. | 19 |
| 29274137 | 2018 | Solute carrier family 35 member F2 is indispensable for papillary thyroid carcinoma progression through activation of transforming growth factor-β type I receptor/apoptosis signal-regulating kinase 1/mitogen-activated protein kinase signaling axis. | 19 |
| 21874247 | 2011 | Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging. | 12 |
| 21874247 | 2011 | Highly expressed SLC35F2 in non-small cell lung cancer is associated with pathological staging. | 12 |
| 20379614 | 2010 | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. | 78 |
| 20379614 | 2010 | Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. | 78 |
Citation
Dessen P
SLC35F2 (solute carrier family 35 member F2)
Atlas Genet Cytogenet Oncol Haematol. 2018-07-01
Online version: http://atlasgeneticsoncology.org/gene/57450/slc35f2-(solute-carrier-family-35-member-f2)
